Abstract
Purpose
To evaluate the effect of the hyperhomocysteinemia on pregnancy rate, implantation rate and abortion rate after IVF.
Method
Data from a total of 48 infertile couples with hyperhomocysteinemia were prospectively collected for this study. All patients underwent a standard down regulation protocol for ovarian stimulation. Oocytes recovery was performed at 36 h after hCG administration. Embryo transfer took place at 48 h after insemination. The patients were matched in two groups that received or did not receive therapy (group A and B respectively) to normalize homocysteine plasma level.
Results
Pregnancy rate, implantation rate and abortion rate varied significantly (p ≤ 0.05) between the two groups. The number and quality of embryos transferred did not differ between the groups.
Conclusion
The results suggest that hyperhomocysteinemia could affect IVF outcome
Similar content being viewed by others
References
Raziel A, Kornberg Y, Friedler S, Schachter M, Sela BA, Ron-El R. Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. Am J Reprod Immun 2001;45:65–71.
Kupferminc MJ, Eldor A, Steinman N. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9–13.
Younis JS, Gonen O, Brenner B. Familiar thrombophilia—the scientific rationale for thrombophilaxis in recurrent pregnancy loss? “Webtrack Debate”. Hum Reprod 1997;12:1389–1390.
Qublan HS, Eid SS, Ababneh HA, Amarin ZO, Smadi AZ, Al-Khafaji FF, et al. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Human Reprod 2006;21:2694–2698.
Azem F, Many A, Yovel I, Amit A, Lessing JB, Kupferminc MJ. Increased rates of thrombophilia in women with repeated IVF failure. Human Reprod 2004;19:368–370.
Steegers-Theunissen RPM, Boers GHJ, Blom HJ. Hyperhomocysteinemia and recurrent spontaneous abortions or abruptio placentae [letter]. Lancet 1992;339:1122–1123.
Legnani C, Palareti G, Grauso F, Sassi S, Grossi G, Piazzi S, et al. Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects. Arterioscler Thromb Vasc Biol 1997;17:2924–9.
Wouters MGAJ, Boers GHJ, Blom HJ. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820–5.
Bennet M. Vitamina B12 deficiency, infertility and recurrent fetal loss. J Reprod Med 2001;46 3:209–12.
Unfried G, Greismacher A, Weismuller W, Huber JC, Tempfer CB. The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage. Obstet Gyn 2002;99:614–9.
Heby O. DNA methylation and polyamines in embryonic development and cancer. Int J Dev Biol 1995;39:753–7.
Nelen WLDM, Bulten J, Steagers EAP, Blom HJ, Hanselaar AGJ, Eskes TKAB. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod 2000;15:953–60.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pacchiarotti, A., Mohamed, M.A., Micara, G. et al. The possible role of hyperhomocysteinemia on IVF outcome. J Assist Reprod Genet 24, 459–462 (2007). https://doi.org/10.1007/s10815-007-9165-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-007-9165-2